Endovastec today announced it received registration approval from Japan Pharmaceuticals and Medical Devices Agency for its Hyperflex balloon catheter.
The Shanghai-based heart device maker designed Hyperflex to assist in the dilation of aortic stent graft. It is the company’s first device approved for marketing in Japan. Hyperflex previously gained CE mark approval in 2016 and is available in South America and Asia.
Get the full story on our sister site, Medical Tubing + Extrusion.